Bright Green Signs Letter Of Intent With Alterola Biotech For Strategic Partnership And Acquisition; Initial Purchase 25% For $4M Remainder For $6M And ~$40M BGXX Stock
Bright Green to acquire 25% of Alterola common stock, followed by proposed acquisition of all remaining Alterola common stock, subject to customary conditions and regulatory and stockholder